Profile
| Metric | Value |
|---|---|
| Full Name | Bausch Health Companies Inc. |
| Ticker | NYSE: BHC |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | bauschhealth.com |
| Employees | 20,700 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $7.63 | |
| Price, 1D Change | +3.11% | |
| Market Cap | $3B | |
| TTM Dividend Yield | - | |
| PE Ratio | 7.87 | |
| Beta | 0.90 | |
| Revenue | $10B | |
| Revenue, 1Y Change | +9.91% | |
| EPS | -$0.13 | |
| EPS, 1Y Change | +92.30% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.00 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | VRX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.13 | |
| EPS Estimate | $3.91 | |
| EPS Est. Change | +3,229.44% | |
| Revenue | $9.63B | |
| Revenue Estimate | $10.18B | |
| Revenue Est. Change | +5.82% | |
| Current Price | $7.63 | |
| Price Target | - | $7.00 |
| Price Tgt. Change | - | -8.26% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.36 | -$1.62 | -148.29% | |
| $3.74 | -$0.13 | -103.34% | |
| $3.91 | N/A | +3,229.44% | |
| $4.19 | N/A | +3,454.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.61B | $8.76B | +1.67% | |
| $9.58B | $9.63B | +0.46% | |
| $10.18B | N/A | +5.82% | |
| $10.52B | N/A | +9.28% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -2.18% | |
| Price, 3Y | +2.14% | |
| Market Cap, 1Y | -1.47% | |
| Market Cap, 3Y | +4.57% | |
| Revenue, 1Y | +9.91% | |
| Revenue, 3Y | +14.12% | |
| EPS, 1Y | +92.30% | |
| EPS, 3Y | +95.27% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $7.63 | |
| SMA 200 | $6.24 | |
| SMA 200 vs Price | -18.27% | |
| SMA 50 | $6.73 | |
| SMA 50 vs Price | -11.85% | |
| Beta | 0.90 | |
| ATR | $0.28 | |
| 14-Day RSI | 67.22 | |
| 10-Day Volatility | 38.68% | |
| 1-Year Volatility | 56.82% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.00 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $9.63B | |
| EPS | -$0.13 | |
| Gross Profit | $6.84B | |
| Gross Margin | 71.10% | |
| Operating Profit | $1.85B | |
| Operating Margin | 19.26% | |
| Net Income | -$72.00M | |
| Net Margin | -0.48% | |
| EBITDA | $2.82B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -16.90 | |
| Current Ratio | 0.86 | |
| Quick Ratio | 0.62 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 0.06 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 7.87 | |
| PS Ratio | 0.28 | |
| PB Ratio | -5.00 | |
| EV/EBITDA | 6.87 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$1.28B | |
| Cash & Equivalents | $1.18B | |
| Total Assets | $26.52B | |
| Current Assets | $5.77B | |
| Total Liabilities | $26.84B | |
| Current Liabilities | $6.75B | |
| Total Debt | $21.84B | |
| Short Term Debt | $2.73B | |
| Accounts Payable | $656.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $7.77B | |
| Operating Expenses | $4.99B | |
| Cost Of Goods Sold | $2.78B | |
| SG&A | $3.30B | |
| D&A | $1.27B | |
| Interest Expense | $0.00 | |
| Income Tax | $239.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.60B | |
| CFI | -$454.00M | |
| CFF | -$868.00M | |
| Capex | $340.00M | |
| Free Cash Flow | $1.26B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| RBC Capital | → | |
| Jefferies | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| Piper Sandler | → | |
| Truist Securities | → | |
| Raymond James | ||
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with BHC
Data Sources & References
- BHC Official Website www.bauschhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/885590/000088559025000051/0000885590-25-000051-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/885590/000088559025000007/0000885590-25-000007-index.htm
- BHC Profile on Yahoo Finance finance.yahoo.com/quote/BHC
- BHC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bhc
FAQ
What is the ticker symbol for Bausch Health Companies Inc.?
The ticker symbol for Bausch Health Companies Inc. is NYSE:BHC
Does Bausch Health Companies Inc. pay dividends?
No, Bausch Health Companies Inc. does not pay dividends
What sector is Bausch Health Companies Inc. in?
Bausch Health Companies Inc. is in the Healthcare sector
What industry is Bausch Health Companies Inc. in?
Bausch Health Companies Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Bausch Health Companies Inc. based in?
Bausch Health Companies Inc. is headquartered in Canada
When did Bausch Health Companies Inc. go public?
Bausch Health Companies Inc. initial public offering (IPO) was on March 29, 1994
Is Bausch Health Companies Inc. in the S&P 500?
No, Bausch Health Companies Inc. is not included in the S&P 500 index
Is Bausch Health Companies Inc. in the NASDAQ 100?
No, Bausch Health Companies Inc. is not included in the NASDAQ 100 index
Is Bausch Health Companies Inc. in the Dow Jones?
No, Bausch Health Companies Inc. is not included in the Dow Jones index
When was Bausch Health Companies Inc. last earnings report?
Bausch Health Companies Inc.'s most recent earnings report was on October 29, 2025
When does Bausch Health Companies Inc. report earnings?
The next expected earnings date for Bausch Health Companies Inc. is February 18, 2026
